Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia

P F Smith; Mary C Birmingham; G A Noskin; Alison K Meagher; Alan Forrest; Craig R Rayner; Jerome J Schentag

doi:10.1093/annonc/mdg211

Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia

P F Smith, Mary C Birmingham, G A Noskin, Alison K Meagher, Alan Forrest, Craig R Rayner, Jerome J Schentag

Centre for Medicine Use and Safety

Research output: Contribution to journal › Article › Research › peer-review

73 Citations (Scopus)

Original language	English
Pages (from-to)	795 - 801
Number of pages	7
Journal	Annals of Oncology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdg211
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdg211

Cite this

@article{6457f8fe79074e4a9999ce65d5a689cf,

title = "Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia",

author = "Smith, {P F} and Birmingham, {Mary C} and Noskin, {G A} and Meagher, {Alison K} and Alan Forrest and Rayner, {Craig R} and Schentag, {Jerome J}",

year = "2003",

doi = "10.1093/annonc/mdg211",

language = "English",

volume = "14",

pages = "795 -- 801",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia

AU - Smith, P F

AU - Birmingham, Mary C

AU - Noskin, G A

AU - Meagher, Alison K

AU - Forrest, Alan

AU - Rayner, Craig R

AU - Schentag, Jerome J

PY - 2003

Y1 - 2003

U2 - 10.1093/annonc/mdg211

DO - 10.1093/annonc/mdg211

M3 - Article

SN - 0923-7534

VL - 14

SP - 795

EP - 801

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -